Merck Partners with Perspective Therapeutics on Trial Collaborations

Perspective Therapeutics has announced a trial collaboration agreement with Merck, a leading pharmaceutical company. The agreement will allow both companies to work together on preclinical and clinical trials for their respective therapies.

Merck has been involved in various collaborations with biotechnology firms in the past, but this is its first partnership with Perspective Therapeutics. The terms of the agreement have not been disclosed.